Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This is an open-label, long-term safety study of glycopyrronium topical wipes, enrolling up
to 660 subjects with primary axillary hyperhidrosis who participated in either the DRM04-HH04
or DRM04-HH05 studies.